Review



ovcar8 engineered with stable gfp overexpression  (Creative Biogene Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Creative Biogene Inc ovcar8 engineered with stable gfp overexpression
    Rapamycin PFC nanoparticles inhibit tumoral angiogenesis without affecting normal vessels, illustrated by CD31 staining (Red). ( A , B ). <t>Tumor</t> from control group ( A ) and the rapamycin PFC nanoparticles-treated group ( B ) (magnification: 20×, scale bar: 50 µm) (Green: <t>Human</t> <t>ovarian</t> tumor <t>cell,</t> OVCAR8, engineered with stable GFP overexpression). ( C , D ). Heart from control group ( C ) and the rapamycin PFC nanoparticles-treated group ( D ) (magnification: 20×, scale bar: 50 µm). ( E , F ). Renal cortex from control group ( E ) and the rapamycin PFC nanoparticles-treated group ( F ) (magnification: 40×, scale bar: 20 µm). ( G , H ). Renal medulla from control group ( G ) and the rapamycin PFC nanoparticles-treated group ( H ) (magnification: 40×, scale bar: 20 µm). ( I , J ). Liver from control group ( I ) and the rapamycin PFC nanoparticles-treated group ( J ) (magnification: 20×, scale bar: 50 µm). Blue: DAPI staining.
    Ovcar8 Engineered With Stable Gfp Overexpression, supplied by Creative Biogene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ovcar8 engineered with stable gfp overexpression/product/Creative Biogene Inc
    Average 90 stars, based on 1 article reviews
    ovcar8 engineered with stable gfp overexpression - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing Mice"

    Article Title: Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing Mice

    Journal: Nanomaterials

    doi: 10.3390/nano14211752

    Rapamycin PFC nanoparticles inhibit tumoral angiogenesis without affecting normal vessels, illustrated by CD31 staining (Red). ( A , B ). Tumor from control group ( A ) and the rapamycin PFC nanoparticles-treated group ( B ) (magnification: 20×, scale bar: 50 µm) (Green: Human ovarian tumor cell, OVCAR8, engineered with stable GFP overexpression). ( C , D ). Heart from control group ( C ) and the rapamycin PFC nanoparticles-treated group ( D ) (magnification: 20×, scale bar: 50 µm). ( E , F ). Renal cortex from control group ( E ) and the rapamycin PFC nanoparticles-treated group ( F ) (magnification: 40×, scale bar: 20 µm). ( G , H ). Renal medulla from control group ( G ) and the rapamycin PFC nanoparticles-treated group ( H ) (magnification: 40×, scale bar: 20 µm). ( I , J ). Liver from control group ( I ) and the rapamycin PFC nanoparticles-treated group ( J ) (magnification: 20×, scale bar: 50 µm). Blue: DAPI staining.
    Figure Legend Snippet: Rapamycin PFC nanoparticles inhibit tumoral angiogenesis without affecting normal vessels, illustrated by CD31 staining (Red). ( A , B ). Tumor from control group ( A ) and the rapamycin PFC nanoparticles-treated group ( B ) (magnification: 20×, scale bar: 50 µm) (Green: Human ovarian tumor cell, OVCAR8, engineered with stable GFP overexpression). ( C , D ). Heart from control group ( C ) and the rapamycin PFC nanoparticles-treated group ( D ) (magnification: 20×, scale bar: 50 µm). ( E , F ). Renal cortex from control group ( E ) and the rapamycin PFC nanoparticles-treated group ( F ) (magnification: 40×, scale bar: 20 µm). ( G , H ). Renal medulla from control group ( G ) and the rapamycin PFC nanoparticles-treated group ( H ) (magnification: 40×, scale bar: 20 µm). ( I , J ). Liver from control group ( I ) and the rapamycin PFC nanoparticles-treated group ( J ) (magnification: 20×, scale bar: 50 µm). Blue: DAPI staining.

    Techniques Used: Staining, Control, Over Expression



    Similar Products

    ovcar8 engineered with stable gfp overexpression  (Creative Biogene Inc)
    90
    Creative Biogene Inc ovcar8 engineered with stable gfp overexpression
    Rapamycin PFC nanoparticles inhibit tumoral angiogenesis without affecting normal vessels, illustrated by CD31 staining (Red). ( A , B ). <t>Tumor</t> from control group ( A ) and the rapamycin PFC nanoparticles-treated group ( B ) (magnification: 20×, scale bar: 50 µm) (Green: <t>Human</t> <t>ovarian</t> tumor <t>cell,</t> OVCAR8, engineered with stable GFP overexpression). ( C , D ). Heart from control group ( C ) and the rapamycin PFC nanoparticles-treated group ( D ) (magnification: 20×, scale bar: 50 µm). ( E , F ). Renal cortex from control group ( E ) and the rapamycin PFC nanoparticles-treated group ( F ) (magnification: 40×, scale bar: 20 µm). ( G , H ). Renal medulla from control group ( G ) and the rapamycin PFC nanoparticles-treated group ( H ) (magnification: 40×, scale bar: 20 µm). ( I , J ). Liver from control group ( I ) and the rapamycin PFC nanoparticles-treated group ( J ) (magnification: 20×, scale bar: 50 µm). Blue: DAPI staining.
    Ovcar8 Engineered With Stable Gfp Overexpression, supplied by Creative Biogene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ovcar8 engineered with stable gfp overexpression/product/Creative Biogene Inc
    Average 90 stars, based on 1 article reviews
    ovcar8 engineered with stable gfp overexpression - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Rapamycin PFC nanoparticles inhibit tumoral angiogenesis without affecting normal vessels, illustrated by CD31 staining (Red). ( A , B ). Tumor from control group ( A ) and the rapamycin PFC nanoparticles-treated group ( B ) (magnification: 20×, scale bar: 50 µm) (Green: Human ovarian tumor cell, OVCAR8, engineered with stable GFP overexpression). ( C , D ). Heart from control group ( C ) and the rapamycin PFC nanoparticles-treated group ( D ) (magnification: 20×, scale bar: 50 µm). ( E , F ). Renal cortex from control group ( E ) and the rapamycin PFC nanoparticles-treated group ( F ) (magnification: 40×, scale bar: 20 µm). ( G , H ). Renal medulla from control group ( G ) and the rapamycin PFC nanoparticles-treated group ( H ) (magnification: 40×, scale bar: 20 µm). ( I , J ). Liver from control group ( I ) and the rapamycin PFC nanoparticles-treated group ( J ) (magnification: 20×, scale bar: 50 µm). Blue: DAPI staining.

    Journal: Nanomaterials

    Article Title: Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing Mice

    doi: 10.3390/nano14211752

    Figure Lengend Snippet: Rapamycin PFC nanoparticles inhibit tumoral angiogenesis without affecting normal vessels, illustrated by CD31 staining (Red). ( A , B ). Tumor from control group ( A ) and the rapamycin PFC nanoparticles-treated group ( B ) (magnification: 20×, scale bar: 50 µm) (Green: Human ovarian tumor cell, OVCAR8, engineered with stable GFP overexpression). ( C , D ). Heart from control group ( C ) and the rapamycin PFC nanoparticles-treated group ( D ) (magnification: 20×, scale bar: 50 µm). ( E , F ). Renal cortex from control group ( E ) and the rapamycin PFC nanoparticles-treated group ( F ) (magnification: 40×, scale bar: 20 µm). ( G , H ). Renal medulla from control group ( G ) and the rapamycin PFC nanoparticles-treated group ( H ) (magnification: 40×, scale bar: 20 µm). ( I , J ). Liver from control group ( I ) and the rapamycin PFC nanoparticles-treated group ( J ) (magnification: 20×, scale bar: 50 µm). Blue: DAPI staining.

    Article Snippet: Human ovarian tumor cells, OVCAR8 engineered with stable GFP overexpression (CSC-RR0468, www.creative-biogene.com (accessed on 16 November 2021)), were maintained in a humidified atmosphere of 95% air and 5% CO 2 at 37 °C in DMEM (Cat#: 11965092, Thermo Fisher Scientific, Waltham, MA, USA) with 10% heat inactivated FBS (Cat#: 16140071, Thermo Fisher Scientific).

    Techniques: Staining, Control, Over Expression